ArticleFrontiers in pharmacology2026

Evolocumab early reduces IL-1β/IL-17A and improves left ventricular function in STEMI: an observational study in the real world.

Menglong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.